Key Investor Information This document provides you with key investor information about this fund. It is not marketing material. The information is required by law to help you understand the nature and the risks of investing in this fund. You are advised to read it so you can make an informed decision about whether to invest.

Global X Telemedicine & Digital Health UCITS ETF (the "Fund"), A sub-fund of Global X ETFs ICAV (the "ICAV") USD Accumulating Share Class, IE00BLR6QB00 The Fund is managed by Global X Management Company (Europe) Limited (the "Manager").

Objectives and Investment Policy The Fund’s investment objective is to generate returns that closely

For Accumulating Shares, income will be automatically reinvested in the correspond, before fees and expenses, generally to the price and yield

Fund and reflected in the NAV per share. performance of the Solactive Telemedicine & Digital Health Index (the “Index”).Investors can buy and sell shares of the Fund on each business day.

Business day means a day on which the New York Stock Exchange and The Fund is passively managed. The Fund will aim to achieve its

London Stock Exchange are open for normal business. investment objective by attempting to track the performance of the Index by investing primarily in a portfolio of equity securities that as far asFor more information about the investment policy and strategy of possible and practicable consists of the component securities of the Index

the Fund, please refer to the sections entitled “Investment in similar proportions to their weightings in the Index and in american

Objective” and “Investment Policy” in the Fund’s Supplement. depositary receipts (“ADRs”) and global depositary receipts (“GDRs”) based on the securities in the Index. The Index aims to provide exposure to exchange-listed companies that are positioned to benefit from advances and application of advances in the field of telemedicine and digital health (collectively “Telemedicine & Digital Health Companies”). A company must derive at least 50% of its revenue, operating income, or assets from telemedicine and/or digital health to be considered for inclusion in the Index. Telemedicine and Digital Health Companies include those involved in the following business activities (i) telemedicine, (ii) healthcare analytics, (iii) connected healthcare devices and/or (iv) administrative digitisation. When not possible or practicable to continue to hold all of the component securities of the Index, the Fund may invest in depositary receipts relating either to components securities of the Index or to equity securities of the type referred to above; and financial derivative instruments (“FDIs”), namely, total return “unfunded” OTC swaps and exchange-traded equity futures for investment purposes. The Fund may enter into securities lending transactions, investing in repurchase and reverse repurchase transactions and collective investment schemes, for the purposes of efficient portfolio management only. The Fund’s base currency is USD.

Risk and Reward Profile

Lower Risk

Higher Risk

Equities Risk: The Fund may invest in equity securities which are

subject to greater fluctuations than other assets. Factors which may

affect the fluctuation including economic conditions, industry or company

Typically lower rewardsTypically higher rewardsnews. High volumes of trading may also see increased transaction costs.

Concentration Risk: The Fund’s investments will be highly concentrated

in Telemedicine & Digital Health Companies. The lack of diversification

1

2

3

4

5

6 7

across the Fund’s portfolio may increase the losses suffered by the Fund

if the this sector were to suffer a downturn. Furthermore, the healthcare This indicator above is based on historical data and may not be a reliable

sector is particularly exposed to risks such as new governmental policies indication of the future risk profile of the Fund. The risk category shown isand regulations, lawsuits relating to patents or products, licensing and not guaranteed and may change over time. The lowest category does notapproval issues and uncertainty regarding the long-term viability of mean a risk-free investment. products.

Market Risk: The risk that the market will go down in value, with the This Fund is in risk category 7 due to the range and frequency of price

possibility that such changes will be sharp and unpredictable. movements (i.e. the volatility) of the underlying investments referenced by the Fund which may not be a reliable indicator of the future risk profile Operational Risk (including safekeeping of assets): The Fund and its of the share class.

assets may experience material losses as a result of technology/system

failures, human error, policy breaches, and/or incorrect valuation of The Fund offers no capital guarantee or protection.

units. Social, political and economic developments and laws differ

between regions. Changes in these may impact the Fund such as any The Fund may be subject to risks which are not included in the

changes that may occur due to the U.K’s withdrawal from the EU calculation of the risk-reward indicator. Key risk factors include:

(Brexit). Currency Risk: Some of the Fund's investments will be denominated in Risks associated with the ability to track an index: Transaction costs currencies other than the Fund’s base currency (USD) therefore investors and other fees and expenses to be borne by the Fund and exchange rate may be affected by adverse movements of the denominated currency factors where the underlying equities are denominated in a different and the base currency. The Fund may attempt to use FDIs to hedge currency to the Base Currency or currency of any Class of Shares are against negative currency movements, however there is no guarantee

likely to affect the ability of a Fund to track the performance of the Index. that any attempts at hedging will be successful. You may receive payments in a different currency, so the final return you will get dependLiquidity Risk: The Fund may invest in securities which may, due to on the exchange rate between the two currencies. This risk is notnegative market conditions, become difficult to sell or may need to be considered in the indicator shown above. sold at an unfavourable price. This may affect the overall value of the Emerging Markets Risk: Investment in emerging markets may expose Fund. the Fund to more social, political, regulatory, and currency risks than securities in developed markets. The fiduciary duties of issuers and the For more information on risks, please see the sections entitled levels of investor protection imposed by regulators is generally less"Risk Factors" in the ICAV's prospectus and in the Fund's comprehensive in emerging market countries than in developed markets.supplement to the ICAV's prospectus. Derivatives Risk: The Fund may invest in FDIs to hedge against risk and/or to increase return. There is no guarantee that the Fund’s use of derivatives for either purpose will be successful. Derivatives are subject to counterparty risk (including potential loss of instruments) and are highly sensitive to underlying price movements, interest rates and market volatility and therefore come with a greater risk. :DocID: KIID_IE00BLR6QB00_en_20260213_6_1_USD_Accumulating_Share_Cl_648883 Charges The charges you pay are used to pay the costs of running the Fund,The entry and exit charges shown are maximum figures. In some cases you including the costs of marketing and distributing the Fund. These might pay less - you can find this out from your financial adviser. charges reduce the potential growth of your investment.

The ongoing charges figure shown here is based on the total expense ratio

of the Fund that the Investment Manager has agreed to cap. The Manager One-off charges taken before or after you invest

gives a commitment to respect the published figure shown and to discharge

any excess amounts out of its own assets for all other fees and expenses

Entry ChargeNone *

over this cap which may arise.

Exit Charge None *

The ongoing charge figure excludes performance fees and portfolio This is the maximum that might be taken out of your money before it istransaction costs, except in the case of an entry/exit charge paid by the

Fund when buying or selling units in another collective investment invested or before the proceeds of your investment are paid out.

undertaking. Charges taken from the Fund over a year:

* Secondary market investors (Investors dealing on a stock exchange) may

pay fees charged by their stock brokers. Such charges, if any, can be Ongoing Charges0.68% **

obtained from stock brokers. Authorised participants dealing directly with Charges taken from the fund under certain specific conditions the Fund will pay related transaction costs related to their subscriptions and

redemptions. Performance Fee

None

** To the extent the Fund undertakes securities lending, the Fund will

receive 87% of the associated revenue generated from securities lending

activities and the remaining 13% will be retained by the securities lending

agent (representing the attendant direct and indirect operational costs and

fees of the securities lending). As securities lending does not increase the

costs of running the fund, this has been excluded from the ongoing charges.

Please refer to the “Fees, Costs and Expenses” section of the ICAV’s

Prospectus and “Fees and Expenses” section of the Supplement to the

Prospectus for further detail on charges and fees for the relevant share

classes.

Past Performance

15%

10.2% Past performance is not an indicator of future results.9.6%

10% The past performance takes account of all charges and costs.5%0% The performance of this class is calculated in US Dollar.

There is insufficient data to produce a useful indication of past

-5%

-2.6%

The Fund was established in 2020.

performance for the share class. -2.0%

-10%

-15%

-14.2%

-13.1%

The class launched on 17 December 2020.-13.6%

-12.9%

-20%

-25%

-30%

-29.5%

-35% -29.1%

2021202220232024

2025USD Accumulating Share ClassSolactive Telemedicine & Digital Health Index (Benchmark)Practical Information Depositary Bank: SEI Investments – Depositary and Custodial Services

Accuracy Statement: The Manager may be held liable solely on the (Ireland) Limited basis of any statement contained in this document that is misleading,

inaccurate or inconsistent with the relevant parts of the ICAV's Further Information: Further information about the ICAV, copies of the

Prospectus. Prospectus and Fund Supplement, latest annual, semi-annual reports and other practical information may be obtained free of charge from

Umbrella Fund: The Fund is a sub-fund of Global X ETFs ICAV, an Irish https://www.globalxetfs.eu and at the registered office of the ICAV.

collective asset-management vehicle constituted as an umbrella fund

with segregated liability between sub-funds. Latest Share Prices/Net Asset Value: The latest share prices will be made available on https://www.globalxetfs.eu or by contacting the Segregated Liability: Under Irish law the assets and liabilities of the Administrator, SEI Investments – Global Fund Services Limited.Fund are segregated from other sub-funds within the ICAV and the

assets of the Fund will not be available to satisfy the liabilities of another Remuneration Policy: Details of the remuneration policy of the Manager

fund of the ICAV. are available on the Manager's website, https://www.globalxetfs.eu. A paper copy will be available free of charge from the office of the ManagerThis Fund is authorised in Ireland and regulated by Central Bank of upon request. Ireland. The Manager is authorised in Ireland and regulated by the

Central Bank of Ireland. Conversion of Shares: A Shareholder may convert shares of one fund into shares of another fund or shares of a class within a fund into shares of a different class within the same fund, switching fees may apply. Notice should be given to the Directors in such form as the Directors may require. Please refer to the Prospectus for the ICAV for further details on how to exercise your right to switch. Tax Legislation: The taxation of income and capital gains of the ICAV and of the Shareholders is subject to the fiscal laws and practices of Ireland, of the countries in which the ICAV invests and of the jurisdictions in which the Shareholders are resident for tax purposes or otherwise subject to tax. Depending on your country of residence, this may impact your personal tax position. For further details, please speak to your financial adviser.

This Key Investor Information is accurate as at 13/02/2026. : DocID: KIID_IE00BLR6QB00_en_20260213_6_1_USD_Accumulating_Share_Cl_648883